Combining dobutamine and norepinephrine during emergency procedures significantly lowers rates of acute kidney injury, clinical trial finds.
RT’s Three Key Takeaways:
- Reduced Kidney Injury: Combining dobutamine and norepinephrine during emergency surgery for septic shock lowered the incidence of postoperative kidney injury to under 25%, compared to roughly 35% with norepinephrine alone.
- Enhanced Organ Perfusion: Patients receiving the dual-infusion protocol produced more urine immediately and exhibited fewer signs of organ strain during their first day in the ICU, without an increase in severe cardiac events.
- Guideline Impact: The clinical trial provides multi-center evidence supporting dobutamine use to maintain renal blood flow during high-risk surgery, addressing previous evidentiary gaps in international sepsis management guidelines.
A clinical protocol combining the heart medications dobutamine and norepinephrine during emergency surgery for septic shock significantly reduces the risk of acute kidney injury (AKI), according to a study published in JAMA.
The trial, conducted through a collaboration between researchers at the University of Southampton and Zhejiang University School of Medicine in China, evaluated whether improving systemic blood flow during surgery protects renal function, according to the University of Southampton.
Septic shock carries a global mortality rate of up to 50% and frequently stems from an overwhelming immune reaction to severe infection. While surgical intervention can clear infection sources, the physiological stress of surgery and ongoing systemic inflammation often trigger AKI. Dr Nazrul Islam, senior co-corresponding author from the University of Southampton, noted that standard medical management during septic shock surgery relies on vasopressors that can constrict vessels and starve the kidneys of blood.
“Our trial discovered that adding these two heart medications during the operation safely boosts blood flow,” said Nazrul Islam, senior co-corresponding author from the University of Southampton, in a news release. “It also significantly cuts the risk of severe kidney damage, offering a safer way to protect vulnerable patients during high-risk surgery.”
Clinical Trial Outcomes and Renal Protection
The multi-center study tracked 584 adult surgical patients across 39 hospitals in China. Half of the participants received an infusion of dobutamine alongside norepinephrine, while the control group received norepinephrine alone.
Within one week following surgery, fewer than 25% of patients in the combination group developed new or worsening kidney injuries, compared to approximately 35% in the group receiving standard care.
“Crucially, we found the therapy was most effective at preventing serious forms of kidney injuries,” said Lihua Chu, study author from Zhejiang University School of Medicine. “Moderate to severe kidney injuries were roughly halved among patients receiving the combined drugs. Patients taking the drug combination produced more urine right away and showed milder overall signs of organ strain during their first day in intensive care.”
Hemodynamic Safety and Clinical Practice
Investigators monitored patients for hemodynamic adverse events. The combination regimen led to higher rates of temporary tachycardia, occurring in 41% of patients receiving the combination compared to roughly 30% receiving norepinephrine alone. However, the researchers reported no increase in major complications, including cardiac arrest or serious arrhythmias.
The findings provide critical data for critical care and perioperative healthcare teams managing sepsis. Previous international recommendations have cited insufficient clinical data to endorse routine dobutamine administration during sepsis resuscitation.
“Our research is timely as the International Guidelines for Management of Sepsis and Septic Shock recently said there was insufficient data to make a recommendation for the use of dobutamine,” said Xiangming Fang, primary corresponding author from Zhejiang University School of Medicine. “Clearly this can now be changed – and we hope our findings can help doctors rethink how they care for patients during high-risk emergency surgery.”
